From: Underestimation of airway luminal eosinophilia by quantitative sputum cytometry
Criteria for assessing eosinophilic inflammation | 1.2%¥ | 2.3%ǁ |
---|---|---|
Treatment of neutrophilia and decrease in corticosteroid dose | 9.2% | 8.7% |
Treatment of neutrophilia | 19.1% | 28.8% |
Decrease in corticosteroid dose | 26.5% | 28.9% |
Disease flare (not attributed to neutrophilia and/or decrease in corticosteroid dose) | 57.8% | 60.5% |